Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Nanobiotechnology|July 29, 2021
Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapyHiroki Kato, Xuhao Huang, Yuichiro Kadonaga, et al.
Scientific Reports|June 22, 2021
Synthesis of [<sup>211</sup>At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solutionYoshifumi Shirakami, Tadashi Watabe, Honoka Obata, et al.
EJNMMI Radiopharmacy and Chemistry|February 26, 2024
Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranosticsYuta Kaizuka, Hiroyuki Suzuki, Tadashi Watabe, et al.
EJNMMI Radiopharmacy and Chemistry|April 15, 2024
Production of [<sup>211</sup>At]NaAt solution under GMP compliance for investigator-initiated clinical trialSadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, et al.
Pharmaceutics|December 23, 2022
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous InjectionXuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, et al.
Oncotarget|April 29, 2020
Targeted alpha therapy using astatine (<sup>211</sup>At)-labeled phenylalanine: A preclinical study in glioma bearing miceTadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, et al.
Medical Physics|September 11, 2020
Development of high-resolution YAP(Ce) x-ray camera for the imaging of astatine-211(At-211) in small animalsKouhei Nakanishi, Seiichi Yamamoto, Tadashi Watabe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 19, 2025
An <sup>211</sup>At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanomaHiroyuki Suzuki, Saki Yamashita, Shoko Tanaka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2022
Targeted α-therapy using astatine (<sup>211</sup>At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compoundTadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, et al.
International Journal of Molecular Sciences|August 26, 2022
Comparison of the Therapeutic Effects of [<sup>211</sup>At]NaAt and [<sup>131</sup>I]NaI in an NIS-Expressing Thyroid Cancer Mouse ModelTadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, et al.
Pageof 5